Financial reports
10-Q
2008 Q3
Quarterly report
10 Nov 08
10-Q
2008 Q2
Quarterly report
11 Aug 08
10-Q
2008 Q1
Quarterly report
8 May 08
10-K
2007 FY
Annual report
17 Mar 08
10-Q
2007 Q3
Quarterly report
8 Nov 07
10-Q
2007 Q2
Quarterly report
8 Aug 07
10-Q
2007 Q1
Quarterly report
10 May 07
10-K
2006 FY
Annual report
16 Mar 07
10-Q
2006 Q3
Quarterly report
14 Nov 06
10-Q
2006 Q2
Quarterly report
9 Aug 06
Current reports
8-K
Cost Associated with Exit or Disposal Activities
3 Mar 09
8-K
Deferral of Near-Term Contractual Cash Payments
17 Feb 09
8-K
Other Events
10 Feb 09
8-K
Acusphere, Inc. Announces Receipt of NASDAQ Panel Decision to Delist Common Stock
7 Jan 09
8-K
Acusphere, Inc. Announces Resignation of Richard Walovitch
7 Jan 09
8-K/A
Financial Statements and Exhibits
7 Jan 09
8-K
Departure of Directors or Principal Officers
18 Dec 08
8-K
Acusphere Announces Results of FDA Advisory Committee Meeting
11 Dec 08
8-K
Regulation FD Disclosure
10 Dec 08
8-K
Other Events
21 Nov 08
Registration and prospectus
D
$2.5M in debt / options / securities to be acquired, sold $2.5M, 1 investor
22 Feb 12
D/A
$10M in debt / options / securities to be acquired, sold $7.5M, 1 investor
7 Jul 11
D
$10M in debt / options / securities to be acquired, sold $5M, 1 investor
16 Jul 10
15-12G
Securities registration termination
3 Mar 09
25-NSE
Exchange delisting
20 Feb 09
REGDEX
Notice of sale of securities
12 Nov 08
S-8
Registration of securities for employees
25 Jul 07
424B5
Prospectus supplement for primary offering
12 Jun 07
424B5
Prospectus supplement for primary offering
7 Dec 06
424B2
Prospectus for primary offering
1 Sep 06
Proxies
DEF 14A
Definitive proxy
28 Apr 08
PRE 14A
Preliminary proxy
17 Apr 08
DEF 14A
Definitive proxy
25 Feb 08
PRE 14A
Preliminary proxy
12 Feb 08
DEF 14A
Definitive proxy
30 Apr 07
DEF 14A
Definitive proxy
28 Apr 06
DEFA14A
Additional proxy soliciting materials
3 Jun 05
DEFA14A
Additional proxy soliciting materials
3 Jun 05
DEF 14A
Definitive proxy
29 Apr 05
DEF 14A
Definitive proxy
17 Sep 04
Other
CT ORDER
Confidential treatment order
10 Jan 17
CORRESP
Correspondence with SEC
21 Feb 08
UPLOAD
Letter from SEC
14 Feb 08
EFFECT
Notice of effectiveness
18 Aug 06
EFFECT
Notice of effectiveness
1 Jun 06
CORRESP
Correspondence with SEC
20 Dec 04
CORRESP
Correspondence with SEC
20 Dec 04
UPLOAD
Letter from SEC
14 Dec 04
CORRESP
Correspondence with SEC
10 Nov 04
CORRESP
Correspondence with SEC
5 Oct 04